Karsten K. Madsen

发表

Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1).

G. Ecker, A. Schousboe, P. Wellendorph, 2017, Journal of medicinal chemistry.

Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs.

A. Schousboe, H. White, Karsten K. Madsen, 2010, Pharmacology & therapeutics.

Deletion of the betaine–GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice

D. Rusakov, P. Laake, A. Schousboe, 2011, Epilepsy Research.

Glutamate Uptake Triggers Transporter-Mediated GABA Release from Astrocytes

M. Palkovits, A. Schousboe, P. Barabas, 2009, PloS one.

Synaptic and extrasynaptic GABA transporters as targets for anti‐epileptic drugs

A. Schousboe, P. Krogsgaard‐Larsen, R. Clausen, 2009, Journal of neurochemistry.

Correction to: Delineation of the Role of Astroglial GABA Transporters in Seizure Control

A. Schousboe, K. Madsen, Karsten K. Madsen, 2017, Neurochemical Research.

Delineation of the Role of Astroglial GABA Transporters in Seizure Control

A. Schousboe, K. Madsen, Karsten K. Madsen, 2017, Neurochemical Research.

Delineation of the Role of Astroglial GABA Transporters in Seizure Control

A. Schousboe, K. Madsen, Karsten K. Madsen, 2017, Neurochemical Research.

The GABA Synapse as a Target for Antiepileptic Drugs: A Historical Overview Focused on GABA Transporters

A. Schousboe, M. Barker-Haliski, H. White, 2014, Neurochemical Research.

Selective mGAT2 (BGT-1) GABA uptake inhibitors: design, synthesis, and pharmacological characterization.

Arne Schousboe, A. Schousboe, P. Krogsgaard‐Larsen, 2013, Journal of medicinal chemistry.

Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control

A. Schousboe, H. White, Karsten K. Madsen, 2012, Neurochemistry International.

Neurotransmitter Transporters and Anticonvulsant Drug Development

A. Schousboe, H. White, K. Madsen, 2011 .

Regulation of excitation by GABA neurotransmission: focus on metabolism and transport.

A. Schousboe, O. Larsson, O. M. Larsson, 2008, Results and problems in cell differentiation.

Functional and Pharmacological Aspects of GABA Transporters

A. Schousboe, B. Frølund, R. Clausen, 2006 .

GABA transport inhibitors and seizure protection: the past and future.

A. Schousboe, H. White, K. Madsen, 2011, Future medicinal chemistry.

Design, synthesis and pharmacological characterization of coumarin-based fluorescent analogs of excitatory amino acid transporter subtype 1 selective inhibitors, UCPH-101 and UCPH-102.

L. Bunch, B. Abrahamsen, Tri H. V. Huynh, 2012, Bioorganic & medicinal chemistry.

Discovery of a subtype selective inhibitor of the human betaine/GABA transporter 1 (BGT-1) with a non-competitive pharmacological profile.

A. Schousboe, R. Clausen, H. Bräuner‐Osborne, 2013, Biochemical Pharmacology.

Selective GABA Transporter Inhibitors Tiagabine and EF1502 Exhibit Mechanistic Differences in Their Ability to Modulate the Ataxia and Anticonvulsant Action of the Extrasynaptic GABAA Receptor Agonist Gaboxadol

A. Schousboe, P. Krogsgaard‐Larsen, H. White, 2011, Journal of Pharmacology and Experimental Therapeutics.

(1S, 3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid (CPP-115), a potent γ-aminobutyric acid aminotransferase inactivator for the treatment of cocaine addiction.

J. Brodie, A. Schousboe, C. Craft, 2012, Journal of medicinal chemistry.

Amino Acid Neurotransmitter Synthesis and Removal

A. Schousboe, L. K. Bak, H. Waagepetersen, 2012 .